Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Kontoyiannis, D P
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. [electronic resource] - The Journal of hospital infection Apr 2003 - 243-58 p. digital
Publication Type: Journal Article; Review
0195-6701
10.1053/jhin.2002.1278 doi
Amphotericin B--chemistry
Anti-Bacterial Agents--therapeutic use
Antifungal Agents--chemistry
Aspergillosis--drug therapy
Candidiasis--drug therapy
Deoxycholic Acid--analogs & derivatives
Drug Combinations
Echinocandins
Fungal Proteins
Humans
Immunocompromised Host
Mycoses--drug therapy
Peptides
Peptides, Cyclic
Phosphatidylcholines--chemistry
Phosphatidylglycerols--chemistry
Triazoles--therapeutic use
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. [electronic resource] - The Journal of hospital infection Apr 2003 - 243-58 p. digital
Publication Type: Journal Article; Review
0195-6701
10.1053/jhin.2002.1278 doi
Amphotericin B--chemistry
Anti-Bacterial Agents--therapeutic use
Antifungal Agents--chemistry
Aspergillosis--drug therapy
Candidiasis--drug therapy
Deoxycholic Acid--analogs & derivatives
Drug Combinations
Echinocandins
Fungal Proteins
Humans
Immunocompromised Host
Mycoses--drug therapy
Peptides
Peptides, Cyclic
Phosphatidylcholines--chemistry
Phosphatidylglycerols--chemistry
Triazoles--therapeutic use